Description:Micafungin, also known by its developmental code FR-179642, is an echinocandin antifungal agent primarily used in the treatment of invasive fungal infections, particularly those caused by Candida and Aspergillus species. It works by inhibiting the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, thereby compromising the structural integrity of the fungus and leading to cell lysis. Micafungin is typically administered intravenously and is characterized by its broad-spectrum antifungal activity, low toxicity, and favorable pharmacokinetic profile. It is often utilized in immunocompromised patients, such as those undergoing chemotherapy or organ transplantation, where the risk of fungal infections is heightened. The substance is generally well-tolerated, with common side effects including infusion-related reactions and mild liver enzyme elevations. Its stability and solubility in aqueous solutions make it suitable for clinical use, and it is classified under the echinocandin class of antifungals, which are derived from fungal sources.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![Pneumocandin A0, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)…](https://static.cymitquimica.com/products/IN/thumb/DA001XST.jpg)
